These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1462922)

  • 21. Fetal supraventricular tachycardia treated with flecainide acetate.
    Perry JC; Ayres NA; Carpenter RJ
    J Pediatr; 1991 Feb; 118(2):303-5. PubMed ID: 1899700
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of flecainide acetate on fetal heart rate variability: a case report.
    van Gelder-Hasker MR; de Jong CL; de Vries JI; van Geijn HP
    Obstet Gynecol; 1995 Oct; 86(4 Pt 2):667-9. PubMed ID: 7675407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function.
    Hughes MM; Trohman RG; Simmons TW; Castle LW; Wilkoff BL; Morant VA; Maloney JD
    Am Heart J; 1992 Feb; 123(2):408-12. PubMed ID: 1736577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL; Jolivette DM; Fredell PA
    Am J Cardiol; 1988 Aug; 62(6):62D-66D. PubMed ID: 3136638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
    Janousek J; Paul T
    Am J Cardiol; 1998 May; 81(9):1121-4. PubMed ID: 9605053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.
    Ebenroth ES; Cordes TM; Darragh RK
    Pediatr Cardiol; 2001; 22(6):483-7. PubMed ID: 11894150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias.
    Wehling M
    Arzneimittelforschung; 2002; 52(7):507-14. PubMed ID: 12189773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flecainide for supraventricular and ventricular arrhythmias in children and young adults.
    Zeigler V; Gillette PC; Ross BA; Ewing L
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):818-20. PubMed ID: 3138905
    [No Abstract]   [Full Text] [Related]  

  • 30. Flecainide toxicity: ECG changes associated with supratherapeutic levels in milk-fed infants.
    Bhatt H; Regan W; Rosenthal E; Bellsham-Revell H
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36731946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases].
    Denjoy I; Lucet V; Do Ngoc D; Magnier S; Casasoprana A; Coumel P
    Arch Mal Coeur Vaiss; 1991 May; 84(5):647-52. PubMed ID: 1910326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
    J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure.
    Kofinas AD; Simon NV; Sagel H; Lyttle E; Smith N; King K
    Am J Obstet Gynecol; 1991 Sep; 165(3):630-1. PubMed ID: 1909841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flecainide for supraventricular tachycardia in children.
    Zeigler V; Gillette PC; Hammill B; Ross BA; Ewing L
    Am J Cardiol; 1988 Aug; 62(6):41D-43D. PubMed ID: 3136635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of flecainide acetate in the treatment of supraventricular tachyarrhythmias.
    Marwick TH; Woodhouse SP
    Am J Cardiol; 1988 Jul; 62(1):171. PubMed ID: 3132846
    [No Abstract]   [Full Text] [Related]  

  • 39. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG; Ikram H; Kenealy M; Levy L
    Am J Cardiol; 1987 Mar; 59(6):607-9. PubMed ID: 3103410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encainide hydrochloride and flecainide acetate: two class 1c antiarrhythmic agents.
    Chase SL; Sloskey GE
    Clin Pharm; 1987 Nov; 6(11):839-50. PubMed ID: 3119276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.